Recommended Free Tools
PharmEasy’s parent, API Holdings, has repaid ₹1,050 crore of reported term debt, but it has not announced an IPO. A standalone listing and a possible merger with its listed diagnostics company, Thyrocare, remain options. Management says it will decide after targeting profitability in the business excluding Thyrocare by September 2027.
What has changed at API Holdings?
Moneycontrol reported on October 5, 2026, that API Holdings repaid ₹1,050 crore of term debt using proceeds from a partial sale of its Thyrocare stake and internal accruals. After the sale, API Holdings retained a 51.02% controlling stake in Thyrocare. The report describes the parent as debt-free, but does not provide a detailed reconciliation of debt and cash balances.
API Holdings is the corporate parent behind PharmEasy. Thyrocare is the group’s listed diagnostics business and could also become part of a future transaction with the parent.
Is PharmEasy planning an IPO?
An IPO is one possible route, not a confirmed plan. API Holdings managing director and CEO Rahul Guha said, “It is too premature to say what path the company will take.” The two options reported by Moneycontrol are an independent IPO of API Holdings or a possible merger with Thyrocare. Guha said the company would decide after reaching its profitability target and would not rush a listing simply to take advantage of favorable market conditions. Moneycontrol’s October 5, 2026 report does not announce an IPO timetable, issue size, price, or new offer filing.
#1 Best Overall
- Clinically Accurate: Easy Operation by two buttons, Advanced Accuracy, No Calibration required.
- Large Multi-Color Backlit Display: The large, oversized numbers make reading the results from this upper arm blood pressure monitoring device a breeze. Coded (GREEN/YELLOW/RED) display tells if your blood pressure readings are optimal or not.
- Easy Management: Manage and track up to 99 readings on your blood pressure monitor and unlimited readings on your smartphone with iHealth's free iOS and Android applications ( iOS 12.0 or later. Android 9.0 or later.Requires Bluetooth 4.0.and up).
- Heart Rhythm Disturbances: This unit automatically identifies and alerts you to any heart rhythm disturbances. If detected, a warning symbol will be displayed after the measurement is taken.
- What You Get: 1 x blood pressure monitor that meets ESH 2010 performance standards, 4 AAA batteries, 1 wide range cuff that fits upper arms with Circumference of 8.7"-16.5" (22-42cm),1 Instruction manual, our worry-free 12-month warranty and friendly California-based customer service.
What profitability target must the company meet?
The reported target is profitability in API Holdings’ business excluding Thyrocare by September 2027. This is different from consolidated profitability: Moneycontrol says the group including Thyrocare is already profitable. It would therefore be inaccurate to read the group-level result as proof that PharmEasy or the parent’s non-Thyrocare business is already profitable.
Losses and expenses reported for the non-Thyrocare business
Moneycontrol reported that the business excluding Thyrocare narrowed its EBITDA loss year over year. The figures below are those cited in the October 2026 report; they are not an independent review of the company’s financial statements.
Rank #2
- LARGE EASY-TO-READ DISPLAY: Bright screen clearly shows SpO2, pulse rate, and signal strength with large digits. The waveform bar graph provides visual confirmation of pulse strength, making it ideal for adults and users who prefer clear visibility.
- PORTABLE & USER-FRIENDLY: Compact, lightweight design fits easily in your pocket or bag. One-button operation makes it simple for anyone to use—just insert your finger and press the button for instant results. Auto power-off preserves battery life.
- PERFECT FOR EVERYDAY & OUTDOOR USE: Great for checking oxygen and pulse levels at home, during workouts, hiking, skiing, or high-altitude trips. A practical tool for fitness lovers, outdoor enthusiasts, and anyone who wants to keep an eye on their daily wellness.
- COMPLETE PACKAGE INCLUDED: Comes with 1x Pulse Oximeter, 2x AAA Batteries , 1x Lanyard for easy carrying, and 1x Instruction Manual. Ready to use right out of the box—no additional purchases needed.
| Fiscal year | EBITDA loss | Operating expenses |
|---|---|---|
| FY24 | ₹637 crore | ₹1,225 crore |
| FY25 | ₹396 crore | ₹1,029 crore |
| FY26 | ₹168 crore | ₹943 crore |
Guha described profitability as a prerequisite for his IPO ambition: “My mission is to take a great company to IPO, and for that I need to be profitable.” The statement explains management’s stated priority; it is not a commitment to list once a target is met.
How do an API Holdings IPO and a Thyrocare merger differ?
| Question | Independent API Holdings IPO | Possible merger with Thyrocare |
|---|---|---|
| Basic route | API Holdings would seek its own listing. | The parent and its listed diagnostics business could be combined; the report does not specify the proposed structure. |
| Timing | Management says it will decide after the non-Thyrocare profitability target. | Management says it will decide after the same target. |
| Ownership and control | Would involve an offering and ownership changes, but no terms are reported. | Could affect the relationship between API Holdings and its 51.02%-owned Thyrocare, but no terms or control outcome are reported. |
| What is known about process | No current timetable or new filing is reported. | No deal terms, timetable, or required transaction steps are reported. |
The available reporting does not establish which route is more likely or more valuable. A merger would involve transaction and regulatory steps, but the details cannot be assessed without a proposed structure.
Quick wins for a faster PC:
Repair Windows errors before they cause bigger problemsFix Now →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Rank #3
- Simple to Use Without a Subscription: No Bluetooth, Wi-Fi, cords or PC needed. Place the device near your smartphone. Monitor your heart by placing your fingers or thumbs on the silver KardiaMobile EKG sensors. Know in 30 seconds whether your heart rhythm is normal.
What happened to the earlier IPO filing?
API Holdings did file IPO paperwork in the past: the Securities and Exchange Board of India’s public-issues record lists “API Holdings Limited IPO – DRHP,” dated November 11, 2021. That is a historical filing, not evidence of a current offer. SEBI’s filing record does not establish a new filing or a current listing schedule.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What does management say about PharmEasy’s business?
Moneycontrol reported that API Holdings is targeting around 15% annual revenue growth, a company plan rather than a guaranteed result. It also reported that around 25% of PharmEasy revenue comes from higher-margin products and services, while about 9% comes from generics and private-label products. Guha characterized the strategy this way: “We are no longer a medicine delivery platform; we are an OPD healthcare platform.” That is management’s description of the business, not independent verification of the strategy’s performance.
Rank #4
- Convenient Dual User Mode: Store up to 240 readings for two users, allowing easy tracking and comparison of measurements
- Fast and Accurate Measurements: Our fully automatic wrist blood pressure machine provides fast and precise results, simply press the "START/STOP" button, and the measurement process takes 35 seconds; the device automatically turns off after 60 seconds of inactivity
- Voice Broadcast Design: Our automatic blood pressure cuff features a voice broadcast function, making it ideal for individuals with poor eyesight; you can adjust the volume or turn off the sound using the SET and MEM buttons
- Large LED Backlit Display: The large LED screen of our blood pressure monitor features clear numbers, ensuring easy readability even in low-light conditions, enjoy a hassle-free visual experience
- Portable Rechargeable Blood Pressure Monitor: Equipped with a built-in rechargeable battery and Type-C cable for convenient charging anytime, eliminating the need for battery replacements and ensuring you can easily monitor your health (Note: Charging adapter not included in the packaging)
For further company materials, API Holdings maintains a financial reports page, listing presentations and statements, including Q1 FY27 materials.
Quick Recap
Best Value
- ACCURATE AND DETAILED EKG RESULTS. KardiaMobile 6L records a medical-grade, six-lead EKG and provides FDA-cleared determinations of your heart rhythm in just 30 seconds.
- SIX LEADS, SIX TIMES THE DATA. Six-lead EKGs give you a more detailed view of your heart and more data to share with your doctor. With KardiaMobile 6L, you can detect AFib, Bradycardia, Tachycardia and Normal Sinus Rhythm right on your smartphone.
- TRUSTED BY PROFESSIONALS: Recommended by doctors, KardiaMobile 6L is the world’s first FDA-cleared six-lead personal EKG
- COMPATIBLE WITH SMARTPHONES. Works with most smartphones and tablets. KardiaMobile 6L is compatible with most popular phones and tablets. To use your Kardia device, you must download the Kardia app on a compatible device. Visit the Kardia store to check the list of compatible devices.
- NO SUBSCRIPTION REQUIRED. Takes a six-lead EKG and detects Atrial Fibrillation, Bradycardia, Tachycardia, and Normal Sinus Rhythm without a KardiaCare subscription.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
